908 Devices (MASS) Return on Invested Capital (2024 - 2026)

908 Devices (MASS) posted quarterly Return on Invested Capital of 0.01% for Q4 2025, up 63.97% quarter-over-quarter from 0.03% in Q3 2025.

908 Devices (MASS) Return on Invested Capital (2024 - 2026) Analysis & Trends

908 Devices (MASS) has reported Return on Invested Capital for 2 consecutive years, with 0.01% the latest figure, recorded in Q4 2025.

In Q4 2025, Return on Invested Capital changed N/A year-over-year to 0.01%; the TTM figure through Dec 2025 stood at 0.01% (changed N/A YoY), while the FY2023 annual figure was 0.05%, changed N/A from the prior year.
Return on Invested Capital improved to 0.01% in Q4 2025 per MASS's latest filing, from 0.03% in the prior quarter.
Across five years, Return on Invested Capital topped out at 0.01% in Q4 2025 and bottomed at 0.58% in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Abbott Laboratories	199.46 Bn	193.86 Bn	7.27 Bn	0.01%
2	Stryker	127.41 Bn	123.93 Bn	4.50 Bn	0.01%
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn	0.01%
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn	0.00%
5	Edwards Lifesciences	51.95 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.30 Bn	32.35 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn	0.01%
8	Koninklijke Philips	26.35 Bn	23.02 Bn	4.55 Bn	0.00%
9	Steris	23.04 Bn	22.55 Bn	684.20 Mn	0.04%
10	908 Devices	385.20 Mn	283.67 Mn	8.34 Mn	0.00%

Download Data